Early "screening" tests It was not until 1882 that the American Congress passed a law limiting the mass immigration that had led to much public disquiet. The law excluded only "criminals, paupers, the insane and other undesirables". However, this last category included the physically diseased, and this led to a rapid screening process at the ports of entry. This was not quite what Emma Lazarus had in mind when she dedicated her sonnet, The New Colossus.' to the Statue of Liberty in New York harbour, the last lines of which are inscribed at the foot of the statue:
Give me your tired, your poor, Your huddled masses yearning to breathe free, The wretched refuse of your teeming shore, Send these, the homeless, tempest-test to me, I lift my lamp beside the golden door.
The screening at ports was carried out by the Marine Hospital Service (later to become the US Public Health Service); one of the medical examiners was the young Victor Heiser, later the author of his autobiography, An American Doctor's Odyssey.' Here he describes his task vividly: the snap judgments, with heart-breaking decisions on those refused admission, such as turning back a whole family because one of the children had trachoma. Some of the tests seem bizarre: for instance the presumptive diagnosis of pregnancy' (illegitimacy being a reason for refusal) by the observation of lacklustre hair hanging dull and lifeless over one ear.
Certain important observations arise from Dr Heiser's account:
• The initial screening was unaccompanied by a definitive examination, except for those immigrants deemed to have readily curable complaints • The stage was set to make the examination as valid as possible under the given conditions by ensuring that the subject was unaware of the examiner, and by excluding the carriage of baggage while observing the would-be immigrants walking on level ground • Despite the attempt at validity, the screening must have been inaccurate to a degree, with many unfairly excluded and others passing through the net unscathed yet having excludable defects. No doubt for demographic and economic reasons tests leant towards a high false positive and low false negative rate • The state was calling the tune and it was easy to arrive at a satisfactory cost/benefit balance -the cost was low, the benefit to the state great; but some immigrants who would have been of cultural benefit would certainly have been excluded. Beethoven and Schumann with probable syphilis and Chopin with pulmonary tuberculosis might well not have been admitted had they by some supernatural power presented themselves • There was effective treatment for those screened positive -return to country of origin; or, in a few cases, hospital treatment • The screening test was accepted by most of the people concerned: they had accepted the admission terms set by the state. Acceptance was not total, however, and some tried to evade screening altogether by travelling cabin class, until the authorities caught up with the loophole.
This cruel example of prescriptive screening for the benefit of the state contrasts well with the kind of screening that followed much later, also in the USA, after the second world war. Immigrant screening was, in effect, a form of multiple screening, in that one observer was simultaneously applying a number of subjective tests. The later form of so-called multiphasic screening was applied with the aim of benefiting the individual.
Multiphasic screening Multiphasic screening, backed by the US Public Health Service, grew and grew and became very popular. An early published report, possibly the first, was that of a multiphasic survey in San Jose in 1948,3 where the city health service screened industrial employees, examining blood, urine, and chest radiographs.
An important assessment of the value of such screening was made by the US Commission on Chronic Illness in 1951,4 in which it gave a well known definition of a screening test, part of which emphasised rapidity of application. The commission identified six criteria: reliability, validity, yield, cost, acceptance, and the need for follow up services. Nothing was said, however, about a need to establish whether the activity led to prevention of illness and improved health. There were many reports of surveys, but little in the way of outcome apart from test results. In 1955 the American Medical Association collated the results of 33 screening surveys" and noted "the greatest obstacle ... is the lack of data on diagnoses resulting from follow-up ...". Nothing was said about outcome.
The motive driving this flood of activity was, I believe, worthy enthusiasm on the part of public health and other authorities to provide a fall back medical service for that section of the population unable to meet medical costs. Unfortunately, the failure to validate many tests -for example, tonometry as a screening test for chronic glaucoma; the lack of know- ledge about disease outcome following early detection; and the lack of arrangements for medical follow up, led to inability to evaluate the benefit. (The last of these failures may well be compared with the sorry results of cervical screening in England and Wales).07
Medical advances tend to waft across the Atlantic and in this instance the chief medical officer at the Department of Health in London, then Sir George Godber, became alerted to these developments in the USA and Canada, particularly to the growth of cervical screening -the "Pap test". As a result, in 1962 I visited the USA and Canada on a WHO fellowship and reported on the medical screening scene, much in the above terms." In a subsequent article in the Lancet" attention was drawn to the need for careful evaluation of tests on the lines advocated by Cochrane as early as 1951 10 II; the article also noted "in deciding whether (presymptomatic treatment) should be given the important factor is the prognosis of the condition with and without treatment". The paper concluded by noting that if we tried to avoid the issues of this type of screening, we might find events shaping policy rather than the other way round; and the suggestion was made for a controlled trial of multiphasic screening within the NHS. The point was also made then that "one of the fundamental problems of screening used as a public health procedure (is that) where a patient consults his own personal doctor, for whatever reason, it is easy for the doctor to make an investigatione.g. take the blood pressure -and keep his own counsel ... but if a 'non-patient' is invited to attend for an examination which he himself (not feeling ill) does not initiate, responsibility is incurred by the authority which has invited him and which finds something wrong." The screener was later referred to by Archie Cochrane as an evangelist "whose cry is 'come unto me, ye faithful, and I will cure your piles'" .12
Randomised controlled trials
At this time, as far as I know, no medical randomised controlled trials, as described by Bradford Hill in the Medical Research Council trials of streptomycin in the treatment of pulmonary tuberculosis, had been carried out on the outcome of screening surveys. 13 14 Uncontrolled projects this side of the Atlantic had been set up -the Varmland study, in Sweden,'!" which Dr Cohen, the first chief scientist at the Department of Health and Social Security, visited with Professor Butterfield and reported on to the department -and here in England the Bedford diabetes survey"!" and, later, a demonstration multiphasic screening survey in Rotherharn." However, Cochrane and his colleagues at the Medical Research Council Epidemiology Unit became interested and, in collaboration with the Department of Health and Social Security, ----------applied the technique of the randomised controlled trial to iron deficiency anaemia'? and chronic glaucoma." At the same time the Bedford diabetes sur-vey blossomed as a randomised controlled trial of treatment of raised blood 1iugar levels organised by Harry Keen and his colleagues." Then, again in collaboration with the Department of Health and Social Security, Walter Holland and his team initiated the randomised controlled trial of multiphasic screening with general practitioners in southeast London."
These studies all proved negative in that the treated fared no better than the controls.
Unfortunately, at the time of my 1962 visit to the States and, particularly, Canada, the popularity of cervical cytology had become so widespread that after consultations between the Department of Health and Social Security and the MRC, its introduction as a service was approved by the department's standing medical advisory committee. No randomised controlled trial could be carried out. As the next best thing Archie Cochrane in Cardiff in collaboration with the Welsh Hospital Board, and Alwyn Smith in Manchester with the Manchester Regional Hospital Board, agreed to carry out programmes of closely monitored intensive screening with the object of comparing these areas with areas with only the "normal" provision of screening. The main finding of these surveys was, not to demonstrate falls in incidence or mortality, but to show, despite Archie Cochrane's previously unrivalled response rates, that women most at risk were the most reluctant to attend for screening.":"
Relevance to modern medical screening
What relevance has all this to modern medical screening? Is there therefore no benefit to be found in screening? The answer is perhaps that the lessons learnt the hard way about the validation of screening procedures are useful in the modern context. For instance, the MRC trials of treatment of mild hypertension have laid down the lines for a rational regimen in the prevention of stroke (albeit the gain is small)"; and the extended treatment trials of borderline diabetes, stemming from the original Bedford survey initiated by the late Clive Sharp, the then Medical Officer of Health, 10 have pointed, as Harry Keen has shown, to the importance of renal microvascular leakage of albumen as a "multiplier" for the risk of arteriosclerosis" and thus to the primacy of the control of personal environmental risk factors -in fact, primary prevention. And the possibilities now open to screening for genetic and prenatal conditions, which really meet the classic criteria of validity are exciting, though ethical problems remain. Incidentally, one of the most successful programmes, that for phenylketonuria, was started in the absence of a randomised controlled trial -fortunately, because the Guthrie test is extremely precise and dietary treatment successful."
Three quotations may help summarise the cautious views expressed in this paper: firstly, There was a strong movement at the time in favour of carrying out controlled trials, and Archie Cochrane of the MRC Epidemiology Unit in Cardiff was probably one of the strongest proponents, but there were others, including some in the Department of Health and Social Security itself, who were equally strongly against them. Harold Hughes, Richard Doll, and Joan Faulkner were quite strongly against carrying out a controlled trial. Work had been carried out in Canada on cervical screening and there was strong pressure from groups such as the Women's National Cancer Control Campaign, and enormous enthusiasm, particularly among well educated, middle class women here to start screening immediately. Also, Sir George Godber had talked to the Canadians and perhaps felt that the evidence in favour of screening was further advanced than it in fact was. This public pressure on the department is probably the main reason that controlled trials were not carried out at the time, and I think it was a great pity.
Professor N Wald, editor, Journal of Medical Screening
Have we got any better at evaluating potential screening tests and, cf so, when and where?
It has been a continual process. In the past even medical treatments -for example, tonsillectomy, were given without proper trials. Knowledge has built up over the years, particularly through the MRC Epidemiology Unit, and nowadays the public is in favour of new treatments and screening programmes being properly assessed before they are introduced -it has become almost a mantra.
